Download MendeleyDesign, synthesis, and X-ray structural studies of a series of highly potent, selective, and drug-like G protein-coupled receptor kinase 5 inhibitors.
Ghosh, A.K., Chen, Y., Gadi, R.K., Sonawane, A., Gamage, S.P., Tesmer, J.G.(2025) Eur J Med Chem 282: 117024-117024
- PubMed: 39549325 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1016/j.ejmech.2024.117024
- Primary Citation Related Structures:
9BRE, 9BRG, 9BRH, 9BRI, 9BRJ - PubMed Abstract:
G protein-coupled receptor kinase 5 (GRK5) has emerged as a potential drug development target against heart failure and cancer. A close homolog, GRK6 represents a therapeutic target for multiple myeloma. We have rationally designed a series of highly selective, potent, noncovalent, and drug-like GRK5 inhibitors. Several inhibitors exhibited low nanomolar GRK5 inhibition and high selectivity over GRK2, and, surprisingly, some were selective for GRK6. We determined high-resolution X-ray crystal structures of several inhibitors in complex with GRK5, which provide molecular insights into the ligand-binding site interactions responsible for GRK5 selectivity and potency.
- Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA. Electronic address: akghosh@purdue.edu.
Organizational Affiliation:
